NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.150
-0.050 (-4.17%)
Jan 2, 2025, 4:00 PM EST - Market closed

NeuroSense Therapeutics Statistics

Total Valuation

NRSN has a market cap or net worth of $26.59 million. The enterprise value is $26.95 million.

Market Cap 26.59M
Enterprise Value 26.95M

Important Dates

The last earnings date was Wednesday, December 18, 2024.

Earnings Date Dec 18, 2024
Ex-Dividend Date n/a

Share Statistics

NRSN has 23.13 million shares outstanding. The number of shares has increased by 42.04% in one year.

Current Share Class 23.13M
Shares Outstanding 23.13M
Shares Change (YoY) +42.04%
Shares Change (QoQ) +5.88%
Owned by Insiders (%) 41.33%
Owned by Institutions (%) 1.14%
Float 13.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.21

Current Ratio 0.21
Quick Ratio 0.20
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.17

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -219.64%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$644,222
Employee Count 18
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +46.50% in the last 52 weeks. The beta is 1.36, so NRSN's price volatility has been higher than the market average.

Beta (5Y) 1.36
52-Week Price Change +46.50%
50-Day Moving Average 1.15
200-Day Moving Average 1.15
Relative Strength Index (RSI) 50.31
Average Volume (20 Days) 496,121

Short Selling Information

The latest short interest is 290,561, so 1.26% of the outstanding shares have been sold short.

Short Interest 290,561
Short Previous Month 324,354
Short % of Shares Out 1.26%
Short % of Float 2.14%
Short Ratio (days to cover) 2.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -11.19M
Pretax Income -10.11M
Net Income -11.60M
EBITDA -11.17M
EBIT -11.19M
Earnings Per Share (EPS) -$0.66
Full Income Statement

Balance Sheet

The company has $344,000 in cash and $19,000 in debt, giving a net cash position of $325,000 or $0.01 per share.

Cash & Cash Equivalents 344,000
Total Debt 19,000
Net Cash 325,000
Net Cash Per Share $0.01
Equity (Book Value) -2.82M
Book Value Per Share -0.14
Working Capital -3.00M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NRSN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -42.04%
Shareholder Yield -42.04%
Earnings Yield -42.52%
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a